Société ACADIA Pharmaceuticals Inc.
Actions
ACAD
US0042251084
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
15,82 USD | +3,60 % | +4,63 % | -49,47 % |
16/05 | Transcript : ACADIA Pharmaceuticals Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM | |
10/05 | ACADIA PHARMACEUTICALS INC. : UBS optimiste sur le dossier | ZM |
Métier
Nombre d'employés: 610
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Davis
CEO | Chief Executive Officer | 63 | 15/07/14 |
Mark Schneyer
DFI | Director of Finance/CFO | 50 | 28/05/20 |
Benir Ruano
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Sanjeev Pathak
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Brendan Teehan
COO | Chief Operating Officer | 56 | 01/07/18 |
Ponni Subbiah
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/19 |
- | - | ||
Kimberly Manhard
PRN | Corporate Officer/Principal | 64 | 30/01 |
Kevin Oliver
PRN | Corporate Officer/Principal | - | 10/07/23 |
Holly Valdiviez
SAM | Sales & Marketing | - | 01/04/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 11/12/15 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 25/11/15 |
Stephen Davis
CEO | Chief Executive Officer | 63 | 15/07/14 |
Don Soland
BRD | Director/Board Member | 65 | 20/03/15 |
Laura Brege
BRD | Director/Board Member | 66 | 01/05/08 |
Stephen Biggar
CHM | Chairman | 53 | 22/01/13 |
James Daly
BRD | Director/Board Member | 63 | 11/01/16 |
Director/Board Member | 66 | 29/09/20 | |
Adora Ndu
BRD | Director/Board Member | 43 | 10/10/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 165 220 884 | 164 419 918 ( 99,52 %) | 0 | 99,52 % |
Coordonnées société
ACADIA Pharmaceuticals, Inc.
12830 El Camino Real Suite 400
92130-3331, San Diego
+858 558 2871
http://www.acadia.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-49,47 % | 2,61 Md | |
+64,23 % | 62,59 Md | |
-2,31 % | 41,18 Md | |
+43,79 % | 40,29 Md | |
-8,29 % | 27,9 Md | |
+11,97 % | 26,21 Md | |
-21,16 % | 19,09 Md | |
+7,54 % | 13,08 Md | |
+27,17 % | 12,05 Md | |
+25,72 % | 12,26 Md |
- Bourse
- Actions
- Action ACAD
- Société ACADIA Pharmaceuticals Inc.